The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The Indian dietary supplements market reached a value of INR 376.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach INR 847.9 Billion by 2027, exhibiting a CAGR of 14% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
A dietary supplement is a concentration of essential nutrients that are either extracted from food sources or are artificially synthesized. The major function of dietary supplements is to fulfill the nutritional requirements of the human body and is usually consumed in the form of a pill, capsule, tablet, or liquid. A supplement can provide nutrition either individually or in combination, depending upon the requirements of the consumer’s body. Dietary supplements are rich in vitamins, minerals, herbs, enzymes, amino acids, and various other ingredients. The primary goal of consuming supplements is to fulfill the nutritional gap in the body in order to prevent diseases and other lifestyle related problems.
The primary factor driving the Indian dietary supplements market is the increasing health consciousness among the consumers. Factors such as changes in eating habits, absence of physical activity and rising sedentary life styles have increased the occurrences of various lifestyle diseases such as diabetes, blood pressure, obesity, cardiovascular problems, etc. Moreover, improving awareness levels have also made consumers more aware on their nutritional requirements. With consumers unable to fulfil their nutritional requirements through their regular diets, they are now recognizing the importance of nutritional supplements to fulfill their nutritional gaps. Other factors driving this market include, rising disposable incomes, upgradation of the healthcare infrastructure, improving distribution networks, etc.
IMARC Group provides an analysis of the key trends in each sub-segment of the India dietary supplements market, along with forecasts at the country and regional level from 2022-2027. Our report has categorized the market based on product type, form, distribution channel, application and end-use.
Breakup by Product Type
Breakup by Form
Breakup by Distribution Channel
Breakup by Application
Breakup by End-Use
Breakup by Region
This report also includes:
The India dietary supplements market is highly fragmented with the presence of several small and large players competing in terms of price and quality. Some of the major players in the market are:
IMARC Group’s latest report provides a deep insight into the Indian dietary supplements market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Indian dietary supplements market in any manner.
|Base Year of the Analysis||2021|
|Segment Coverage||Product Type, Form, Distribution Channel, Application, End-Use, Region|
|Region Covered||North India, East India, West and Central India, South India|
|Companies Covered||Amway India Enterprises Private Limited, Herbalife International India Private Limited, Dabur India Limited, Abbott India Limited, Kraft Heinz India Private Limited, Himalaya Drug Company, Sun Pharmaceutical Industries Limited, GlaxoSmithKline Consumer Healthcare Limited, Danone Nutricia International Private Limited and Patanjali Ayurved Limited|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
According to the estimates by IMARC Group, the India dietary supplements market is expected to witness a CAGR of 14% during 2022-2027.
Sudden outbreak of the COVID-19 pandemic had led to the increasing consumption of dietary supplements for improving the immune system to combat coronavirus infection, thereby augmenting the market growth in India.
The rising consumer awareness towards the importance of proper nutritional intake, coupled with with the changing food habits are some of the key drivers for the India dietary supplements market.
Several upgradations in the healthcare infrastructures, along with the improving distribution networks in the country, represents some of the key trends in the India dietary supplements market.
On the basis of the product type, the market has been bifurcated into vitamin and mineral dietary supplements, herbal dietary supplements, protein dietary supplements, and others. Amongst these, vitamin and mineral dietary supplements account for the largest market share.
On the basis of the form, the market has been divided into tablets, capsules, powders, liquids, soft gels, and gel caps. At present, tablets exhibit a clear dominance in the market.
On the basis of the distribution channel, the market has been segregated into pharmacies and drug stores, supermarkets and hypermarkets, online channels, and others. Amongst these, pharmacies and drug stores hold largest market share.
The key companies in the India dietary supplements market are Amway India Enterprises Private Limited, Herbalife International India Private Limited, Dabur India Limited, Abbott India Limited, Kraft Heinz India Private Limited, Himalaya Drug Company, Sun Pharmaceutical Industries Limited, GlaxoSmithKline Consumer Healthcare Limited, Danone Nutricia International Private Limited, Patanjali Ayurved Limited, etc.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at